Citigroup
ANRO icon

Citigroup’s Alto Neuroscience ANRO Stock Holding History

Citigroup’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$212K Sell
9,430
-3,136
-25% -$58.1K ﹤0.01% 3982
2025
Q4 		$224K Buy
+12,566
New +$158K ﹤0.01% 3949
2025
Q3 		– Sell
-2,303
Closed -$5.07K – 6356
2025
Q2 		$5.07K Sell
2,303
-12,841
-85% -$30.6K ﹤0.01% 5278
2025
Q1 		$32.7K Sell
15,144
-1,705
-10% -$6.1K ﹤0.01% 4991
2024
Q4 		$71.3K Buy
16,849
+1,383
+9% +$8.63K ﹤0.01% 4972
2024
Q3 		$177K Buy
15,466
+13,513
+692% +$165K ﹤0.01% 4422
2024
Q2 		$20.9K Sell
1,953
-31,889
-94% -$415K ﹤0.01% 4988
2024
Q1 		$519K Buy
+33,842
New +$530K ﹤0.01% 3546

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citigroup's ANRO Position: Q1 2026 in Review

Citigroup reduced its Alto Neuroscience (ANRO) stake by 25% in Q1 2026, selling an estimated $58.1K and leaving 9,430 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #3982.

Citigroup first reported a position in ANRO in Q1 2024 and has held it in 8 quarters since. The position peaked at $519K in Q1 2024. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Citigroup held 9,430 shares of Alto Neuroscience worth $212K as of Q1 2026.
  • Citigroup sold 3,136 Alto Neuroscience shares in Q1 2026, an estimated $58.1K.
  • Alto Neuroscience made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3982 holding.
  • Citigroup first reported a position in Alto Neuroscience in Q1 2024 and has held it in 8 quarters since.
  • Citigroup's Alto Neuroscience position peaked at $519K in Q1 2024.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.